Relationship between latent and rebound viruses in a clinical trial of anti–HIV-1 antibody 3BNC117

A clinical trial was performed to evaluate 3BNC117, a potent anti–HIV-1 antibody, in infected individuals during suppressive antiretroviral therapy and subsequent analytical treatment interruption (ATI). The circulating reservoir was evaluated by quantitative and qualitative viral outgrowth assay (Q...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Yehuda Z., Lorenzi, Julio C.C., Krassnig, Lisa, Barton, John P., Burke, Leah, Pai, Joy, Lu, Ching-Lan, Mendoza, Pilar, Oliveira, Thiago Y., Sleckman, Christopher, Millard, Katrina, Butler, Allison L., Dizon, Juan P., Belblidia, Shiraz A., Witmer-Pack, Maggi, Shimeliovich, Irina, Gulick, Roy M., Seaman, Michael S., Jankovic, Mila, Caskey, Marina, Nussenzweig, Michel C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rockefeller University Press 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122972/
https://www.ncbi.nlm.nih.gov/pubmed/30072495
http://dx.doi.org/10.1084/jem.20180936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122972/
https://www.ncbi.nlm.nih.gov/pubmed/30072495
http://dx.doi.org/10.1084/jem.20180936

Ejemplares similares